
BIOTE CORP -A
BTMD · NASDAQ
Updated at 2026-10-15 06:51:57
- Today's High
- $1.20
- Today’s Low
- $1.06
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.06
- Previous Close
- $1.13
- Volume
- 144.78K
- Market Cap
- $40.59M
- P/E Ratio
- 6.93X
- EPS
- $0.11
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- MEDICAL CARE FACILITIES
- Headquarters
- 1875 W. WALNUT HILL LN #100, IRVING, TX, UNITED STATES, 75038
- Country
- US
- Listing Date
- 2021-03-02
- Fiscal Year End
- December
- Shares Outstanding
- 37.58M
- CIK
- 0001819253
- Website
- haymakeracquisition.com
biote corp. The company is headquartered in Irvine, Texas.
Financial Metrics
Revenue
2026-06-30
$44.23M
2026-03-31
$44.93M
2025-12-31
$46.4M
2025-09-30
$47.95M
Operating Expenses
2026-06-30
$17.11M
2026-03-31
$27.78M
2025-12-31
$24.74M
2025-09-30
$26.15M
Net Income
2026-06-30
-$6.56M
2026-03-31
$2.27M
2025-12-31
$1.95M
2025-09-30
$8.18M
Net Profit Margin
2026-06-30
-14.83%
2026-03-31
5.06%
2025-12-31
4.21%
2025-09-30
17.07%
Earnings Per Share
2026-06-30
$0.10
2026-03-31
$0.08
2025-12-31
$0.07
2025-09-30
$0.22
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.98M
2026-03-31
$6.29M
2025-12-31
$9.02M
2025-09-30
$12.13M
Effective Tax Rate
2026-06-30
-4.15%
2026-03-31
19.83%
2025-12-31
53.29%
2025-09-30
-9.05%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $44.23M | $44.93M | $46.4M | $47.95M |
| Operating Expenses | $17.11M | $27.78M | $24.74M | $26.15M |
| Net Income | -$6.56M | $2.27M | $1.95M | $8.18M |
| Net Profit Margin | -14.83% | 5.06% | 4.21% | 17.07% |
| Earnings Per Share | $0.10 | $0.08 | $0.07 | $0.22 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.98M | $6.29M | $9.02M | $12.13M |
| Effective Tax Rate | -4.15% | 19.83% | 53.29% | -9.05% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.